China Seismological Network officially determined that an earthquake of magnitude 5.2 occurred in Fiji Islands (14.95 degrees south latitude and 178.15 degrees west longitude) at 09: 51 on December 12, with a focal depth of 10 kilometers.An earthquake with a magnitude of 5.6 occurred in the sea area northeast of Fiji. According to the measurement of the European and Mediterranean Earthquake Center, at 13: 51 local time on December 12th, a magnitude of 5.6 earthquake occurred in the sea area 478 kilometers northeast of Suva, Fiji (15.201 degrees south latitude and 178.282 degrees west longitude) with a focal depth of 10 kilometers.Survey: More than 40% of analysts expect the Bank of Japan to raise interest rates this month, but most think that January next year is the best time. According to the latest survey, observers of the Bank of Japan predict that January is the most likely time to raise interest rates next time, but more than 40% of the respondents still expect to take action next week. According to the survey, about 52% of the 52 economists surveyed expect the Bank of Japan to raise the policy interest rate from 0.25% in January, compared with 32% in the last survey. About 44% of the respondents expect the central bank to take action at the end of the two-day meeting on December 19, down from 53% in the last survey. The survey results show that observers believe that the Bank of Japan's policy meeting this month is likely to move or not to move to a large extent. About 88% of the respondents said that the earliest possible time to raise interest rates in their risk scenarios is next week. Another equally high data shows that Japan's economic and price environment will justify raising interest rates this month.
The next "explosion point" of biomedicine may appear in Shenzhen. "China's pharmaceutical innovation ranks first in the second echelon in the world in terms of the quantitative indicators of R&D pipelines and listed new drugs." A few days ago, Song Ruilin, executive president of China Pharmaceutical Innovation Promotion Association, held the "Star of the Bay Area" biomedical source innovation conference in Shenzhen, and believed that China's pharmaceutical research and industrial development were entering a new stage of innovation. Chen Qiyu, vice president of China Pharmaceutical Innovation Promotion Association and executive director and co-CEO of Fosun International, said that Shenzhen has great advantages and development momentum in linking Greater Bay Area's urban development and AI technology. By leveraging the resources in the Bay Area and making good use of these advantages, it is possible to find a new fulcrum in the future biomedical R&D innovation track, and the next "explosion point" of biomedicine is likely to appear in Shenzhen.Genting Xinyao: The first prescription of itramod in Macau, China officially benefited Asian patients. Genting Xinyao announced that its first prescription of itramod was made in Jinghu Hospital in Macau, China on December 11th, which was the first prescription made by itramod after it was approved in Genting Xinyao Asia Authorized Zone, marking that this heavy product in the field of autoimmune diseases officially began to benefit Asian patients. Luo Yongqing, CEO of Genting Xinyao, said that the arrival of the first prescription of Ithmod in China and Macau was another milestone in the commercialization of Genting Xinyao. By 2030, the number of patients with ulcerative colitis in China is expected to more than double that in 2019, reaching about 1 million. There is a huge unmet demand for innovative therapies. Following the approval in Macau in April this year, Iturmod, as the third commercial new drug of Genting Xinyao, will bring new treatment options to more patients with ulcerative colitis.Trump said that he chose Kari Lake as the director of VOA.
Consumer stocks in Hong Kong stocks fluctuated higher, with the same journey rising by more than 6%, Mengniu Dairy rising by more than 4%, and China Resources Beer, Master Kong Holdings and Haidilao rising.The annual passenger flow at the West Kowloon Station Port exceeded 25 million for the first time. It was learned from the West Kowloon Border Inspection Station of Shenzhen Border Inspection Station that as of 24: 00 on December 11th, the cumulative passenger flow at the West Kowloon Border Inspection Station exceeded 25 million for the first time this year, accounting for 36.7% of the total passenger flow since the opening of the West Kowloon Station Port, an increase of 36.5% compared with last year, an increase of 33% on average daily passenger flow, and 32.5% of foreign passengers entering the country without visas. Inspection ensures that cross-border trains increase by 36% year-on-year, and "customs clearance flow" helps "economic growth", injecting border inspection momentum into the country's high-level open and high-quality development. (Voice of Greater Bay Area)The turnover of Shanghai and Shenzhen stock markets exceeded 1 trillion for the 52nd consecutive trading day, exceeding 10 billion compared with yesterday.
Strategy guide
12-13
Strategy guide
12-13